NEI Translational Research Program for Therapeutics (R61/R33 Clinical Trial Not Allowed)
The National Eye Institute’s Translational Research Program supports rapid translation of lab innovations into therapeutics for visual system diseases. It provides a milestone-driven pathway starting with an R61 (up to 2 years) to advance preclinical findings and then an R33 (up to 4 years) to carry a single therapeutic candidate through IND/IDE-enabling work and preparation for near-term clin…
Source
Dates
Eligibility
Keywords
Supporting Links
Documents
Similar Opportunities
-
Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed)
National Institutes of Health
-
DoW Vision, Translational Research Award
Dept. of the Army -- USAMRAA
-
Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Not Allowed)
National Institutes of Health
-
DoW Vision, Investigator-Initiated Research Award
Dept. of the Army -- USAMRAA
-
NIAID Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required)
National Institutes of Health
Find tens of thousands more opportunities — free
Scout accounts are free. Sign up to browse the full funding database, unlock the solicitation links and documents for this opportunity, and see how well each one fits your organization.
-
Tens of thousands of funding opportunities
Search and filter every grant and solicitation in Scout — all free, no credit card required.
-
Instant Fit Analysis
Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
-
Source links & full documents
Jump straight to the solicitation and download every attachment.
-
Save opportunities & track deadlines
Keep the opportunities that fit in one place and stay ahead of every due date.
Already have an account? Sign In
Trusted by 500+ Happy Customers